NL8300727A - Nieuwe glycoproteinen, werkwijzen ter bereiding daarvan alsmede therapeutische anti-tumormiddelen die dergelijke glycoproteinen bevatten. - Google Patents

Nieuwe glycoproteinen, werkwijzen ter bereiding daarvan alsmede therapeutische anti-tumormiddelen die dergelijke glycoproteinen bevatten. Download PDF

Info

Publication number
NL8300727A
NL8300727A NL8300727A NL8300727A NL8300727A NL 8300727 A NL8300727 A NL 8300727A NL 8300727 A NL8300727 A NL 8300727A NL 8300727 A NL8300727 A NL 8300727A NL 8300727 A NL8300727 A NL 8300727A
Authority
NL
Netherlands
Prior art keywords
sulfuric acid
acid reaction
reaction
cells
color
Prior art date
Application number
NL8300727A
Other languages
English (en)
Dutch (nl)
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57028993A external-priority patent/JPS58146293A/ja
Priority claimed from JP57028992A external-priority patent/JPS58148826A/ja
Priority claimed from JP57087675A external-priority patent/JPS58203918A/ja
Priority claimed from JP57087674A external-priority patent/JPS58203917A/ja
Priority claimed from JP57108046A external-priority patent/JPS58225024A/ja
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of NL8300727A publication Critical patent/NL8300727A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NL8300727A 1982-02-26 1983-02-25 Nieuwe glycoproteinen, werkwijzen ter bereiding daarvan alsmede therapeutische anti-tumormiddelen die dergelijke glycoproteinen bevatten. NL8300727A (nl)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP2899382 1982-02-26
JP2899282 1982-02-26
JP57028993A JPS58146293A (ja) 1982-02-26 1982-02-26 抗腫瘍性糖蛋白質の製造方法
JP57028992A JPS58148826A (ja) 1982-02-26 1982-02-26 糖蛋白質および腫瘍治療剤
JP8767482 1982-05-24
JP8767582 1982-05-24
JP57087675A JPS58203918A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製造法ならびに腫瘍治療剤
JP57087674A JPS58203917A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製法ならびに腫瘍治療剤
JP10804682 1982-06-23
JP57108046A JPS58225024A (ja) 1982-06-23 1982-06-23 糖蛋白質およびその製造方法ならびに腫瘍治療剤

Publications (1)

Publication Number Publication Date
NL8300727A true NL8300727A (nl) 1983-09-16

Family

ID=27521092

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8300727A NL8300727A (nl) 1982-02-26 1983-02-25 Nieuwe glycoproteinen, werkwijzen ter bereiding daarvan alsmede therapeutische anti-tumormiddelen die dergelijke glycoproteinen bevatten.

Country Status (17)

Country Link
US (1) US4481137A (ro)
BE (1) BE896027A (ro)
BR (1) BR8300933A (ro)
DD (1) DD209634A5 (ro)
DE (1) DE3306297A1 (ro)
DK (1) DK93383A (ro)
FI (1) FI830638L (ro)
FR (1) FR2522267A1 (ro)
GB (1) GB2117385B (ro)
GR (1) GR78097B (ro)
LU (1) LU84662A1 (ro)
NL (1) NL8300727A (ro)
NO (1) NO830669L (ro)
PL (1) PL240784A1 (ro)
PT (1) PT76296B (ro)
RO (1) RO85901B (ro)
SE (1) SE8301073L (ro)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
DE3334405A1 (de) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
US5683688A (en) 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US4959457A (en) * 1984-05-31 1990-09-25 Genentech, Inc. Anti-lymphotoxin
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
JPH0631318B2 (ja) * 1985-09-18 1994-04-27 株式会社林原生物化学研究所 新リンホカインｉｉｉとその製法
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
JPH03501620A (ja) * 1988-07-15 1991-04-11 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク 腫瘍壊死増強因子並びに製造及び使用の方法
US5106745A (en) * 1989-12-06 1992-04-21 Board Of Regents, The University Of Texas System Broad spectrum virus inhibitor, UTI-β
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
WO1998041230A1 (fr) * 1997-03-14 1998-09-24 Snow Brand Milk Products Co., Ltd. Agent preventif et/ou curatif de la cachexie
BG65084B1 (bg) * 2002-03-13 2007-02-28 Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А" Нов клас биоактивни гликопротеини
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
EP1648286B1 (en) * 2003-07-12 2017-12-20 Accelerate Diagnostics, Inc. Sensitive and rapid biodetection
US7341841B2 (en) * 2003-07-12 2008-03-11 Accelr8 Technology Corporation Rapid microbial detection and antimicrobial susceptibility testing
EP2683831B1 (en) 2011-03-07 2015-09-23 Accelerate Diagnostics, Inc. Rapid cell purification systems
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US10023895B2 (en) 2015-03-30 2018-07-17 Accelerate Diagnostics, Inc. Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2726886A1 (de) * 1977-06-15 1979-01-18 Behringwerke Ag Neues glykoprotein und verfahren zu dessen herstellung
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage

Also Published As

Publication number Publication date
DD209634A5 (de) 1984-05-16
GB2117385B (en) 1985-05-09
NO830669L (no) 1983-08-29
US4481137A (en) 1984-11-06
RO85901B (ro) 1985-01-30
SE8301073D0 (sv) 1983-02-25
DE3306297A1 (de) 1983-09-15
GB2117385A (en) 1983-10-12
SE8301073L (sv) 1983-08-27
LU84662A1 (fr) 1983-09-08
GR78097B (ro) 1984-09-26
RO85901A (ro) 1985-01-24
FR2522267A1 (fr) 1983-09-02
PT76296A (en) 1983-03-01
FI830638L (fi) 1983-08-27
BE896027A (fr) 1983-08-25
FI830638A0 (fi) 1983-02-25
PL240784A1 (en) 1983-11-07
PT76296B (en) 1985-11-12
BR8300933A (pt) 1983-11-16
GB8305330D0 (en) 1983-03-30
DK93383D0 (da) 1983-02-25
DK93383A (da) 1983-08-27

Similar Documents

Publication Publication Date Title
NL8300727A (nl) Nieuwe glycoproteinen, werkwijzen ter bereiding daarvan alsmede therapeutische anti-tumormiddelen die dergelijke glycoproteinen bevatten.
DK169479B1 (da) Fremgangsmåde til fremstilling af humanspecifikt type II-interferon
NL192086C (nl) Werkwijze ter bereiding van interferonen en werkwijze ter bereiding van een geneesmiddel dat interferonen bevat.
Paronetto Immunologic factors in alcoholic liver disease
WO1999051720A2 (en) Methods for production of therapeutic cytokines
KR930004596B1 (ko) 신규 림포킨(lymphokine) 및 이에 대해 특이성을 갖는 모노클로날(monoclonal) 항체의 제조 방법
US4728637A (en) Complex of macromolecules extracted from mesenchymal cells for treating chronic degenerative disease
WO2022183539A1 (zh) 一种用于治疗脓毒症的药物组合物及其应用
JPS58107197A (ja) ツモアネクロシスフアクタ−の製造方法
JPS6245208B2 (ro)
JPS59141519A (ja) 制ガン作用を有する蛋白質
KR950008569B1 (ko) 신규 림포카인(lymphokine) 및 그 제조방법과 사용방법
JPS58203918A (ja) 糖蛋白質およびその製造法ならびに腫瘍治療剤
US20020155097A1 (en) Antitumor and antiviral medications and method for producing the same
FI77157B (fi) Foerfarande foer framstaellning av glykobunden antigen och foerfarande foer framstaellning av foer kancerceller toxiska lymfocyter, som aer specifika mot denna antigen.
JPS58203917A (ja) 糖蛋白質およびその製法ならびに腫瘍治療剤
JPH0764744B2 (ja) 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤
KR870001433B1 (ko) 적상적혈구(的狀赤血球) 붕괴인자의 제조 방법
JPH0446928B2 (ro)
RU2134581C1 (ru) Средство для лечения облученных млекопитающих
JP2532025B2 (ja) 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
JPS62236495A (ja) ヒト　ツモア・ネクロシス・フアクタ−の製造方法
NO850152L (no) Fremgangsmaate ved fremstilling av human, endogen cancerregulerende faktor.
EP0195681B1 (en) Tumor cytostatic-cytocidal factor and method of obtaining same
JP3660230B2 (ja) 天然型抗腫瘍性又は抗ウイルス性物質およびその用途

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BA A request for search or an international-type search has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed